Nephrology Test Opportunity Drives Behrman Buy-Out Of Athena Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
Behrman Capital's agreement to purchase the Athena Diagnostics unit from Elan illustrates the private equity firm's commitment to commercializing Athena's esoteric nephrology testing capabilities